MediWound to Report First Quarter 2026 Financial Results
MediWound (Nasdaq: MDWD) will release first quarter 2026 financial results for the period ended March 31, 2026 on Wednesday, May 27, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MediWound (Nasdaq: MDWD) will release first quarter 2026 financial results for the period ended March 31, 2026 on Wednesday, May 27, 2026. A conference call and live webcast will follow at 8:30 a.m. Eastern Time for management commentary and a corporate update.
Dial-in numbers and webcast access are provided; an archived replay will be available on the company’s Investors website.
Details
News Market Reaction – MDWD
On May 7, the day this news came out, MDWD closed 0.58% below the previous close.
Data tracked by StockTitan Argus for the May 7 session.
Key Figures
- Earnings release date
- May 27, 2026
- Scheduled first quarter 2026 financial results release
- Quarter end date
- March 31, 2026
- First quarter 2026 period end referenced in release
- Conference call time
- 8:30 a.m. Eastern Time
- Scheduled time for Q1 2026 results call and webcast
- US toll-free number
- 1-844-676-8833
- Dial-in number for the conference call (U.S.)
- Israel dial-in
- 1-809-212373
- Dial-in number for the conference call (Israel)
- International dial-in
- 1-412-634-6869
- Dial-in number for the conference call (international)
Previous Earnings date Reports
-
Announced date and time for Q4 and full-year 2025 earnings call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MediWound to Report First Quarter 2026 Financial Results
Conference Call and Webcast Scheduled for Wednesday, May 27th at 8:30 a.m. Eastern Time
YAVNE, Israel, May 7, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the first quarter ended March 31, 2026 on Wednesday, May 27, 2026.
Following the release, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update.
Conference Call & Webcast Details
Toll-Free: 1-844-676-8833
Israel: 1-809-212373
International: 1-412-634-6869
Webcast: Click HERE
To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay on the Investors section of the MediWound website.
About MediWound
MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company pioneering enzymatic, non-surgical therapies for tissue repair. The company’s FDA-approved biologic, NexoBrid®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the United States, European Union, Japan, and additional international markets. MediWound’s late-stage pipeline product, EscharEx®, is an investigational therapy for the debridement of chronic wounds, with potential to become a new standard of care in wound management.
For more information, visit www.mediwound.com and follow us on LinkedIn and X (formerly Twitter).
MediWound Contacts:
Hani Luxenburg Daniel Ferry
Chief Financial Officer Managing Director
MediWound Ltd. LifeSci Advisors, LLC
ir@mediwound.com daniel@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.